Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
10/2001
10/17/2001EP1143933A2 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
10/17/2001EP0833818B1 3-acylindoles as cb2 receptor agonists
10/17/2001CN1318063A Process for obtaiing HMG-CoA reductase inhibitors of high purity
10/17/2001CN1317965A Compounds having IgE affecting properties
10/17/2001CN1317789A Dipyrrole methylene radical-metallic chelate and optical recording medium made of it
10/17/2001CN1317484A Fullerene derivative of E-isomer
10/17/2001CN1317480A One-step process for synthetizing 2-oxazolidone derivative
10/17/2001CN1073111C Process for preparation of 2,3-pyridinedicarboximides
10/17/2001CN1073090C 1,3,4-oxadiazine derivatives and their use as pesticides
10/17/2001CN1073081C Naphthol derivatives and process for producing same
10/17/2001CN1072932C Method of preventing emesis and treating sexual dyfunction using tetra hydrobenz [CD] indole-6-carboxamides
10/16/2001US6303837 Process for synthesizing α-substituted ring systems
10/16/2001US6303786 Salt formation in a solvent
10/16/2001US6303783 1- (3-Heterocyclylphenyl) isothiourea, -isourea, -guanidine and -amidine herbicidal agents
10/16/2001US6303659 Administering adamantane derivative for therapy of rheumatoid arthritis
10/16/2001US6303628 Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents
10/16/2001US6303611 For therapy of hyperalgesis
10/16/2001US6303610 Method of treating gout with certain indole compounds
10/16/2001US6303600 Substituted azabicyclic compounds
10/16/2001CA2098302C Medicaments
10/11/2001WO2001075137A1 Process for producing optically active 7-substituted-3-(2-aminopropyl)indole derivatives and intermediates for producing the same
10/11/2001WO2001074815A2 Phenyl-substituted imidazopyridines
10/11/2001WO2001074814A1 Phenyl-substituted indolizine derivatives and their use as histamine h3 ligands
10/11/2001WO2001074813A2 METHOD FOR USING 2- OR 3-ARYL SUBSTITUTED IMIDAZO[1,2-a] PYRIDINES AS H3 ANTAGONISTS
10/11/2001WO2001074810A2 Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists
10/11/2001WO2001074775A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
10/11/2001WO2001074774A1 Ethylenediamine derivatives
10/11/2001WO2001074773A2 Phenyl-substituted indoles as histamine h3-receptor antagonists
10/11/2001WO2001074770A1 C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides
10/11/2001WO2001074487A1 Method of separating imide compound
10/11/2001WO2001022951A3 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
10/11/2001WO2001021587A3 Hydroxyfunctional amide 1h-indole derivatives active as spla2 inhibitors
10/11/2001WO2000050376A9 Efficient synthesis of alkyl carbonates
10/11/2001WO2000048606A9 Compositions and methods for use in targeting vascular destruction
10/11/2001US20010029299 Psychological disorders; sleep disorders; anticonvulsants; cognition activators; drug abruse
10/11/2001DE10016544A1 New phenyl-substituted cyclic keto-enol compounds useful e.g. as insecticides, acaricides, nematocides, acaricides, herbicides, ectoparasiticides, antifouling agents or intermediates
10/11/2001CA2829534A1 C2-phenyl-substituted cyclic keto-enols as pesticides and herbicides
10/11/2001CA2405144A1 Ethylenediamine derivatives
10/11/2001CA2404868A1 C2-phenyl-substituted cyclic keto-enols as pesticides and herbicides
10/11/2001CA2404592A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
10/10/2001EP1142874A2 Intermediates for preparing the R or S enantiomer of 1-[9'H-carbazol-4'-yloxy]-3-[ 2''-(2'''- methoxy -phenoxy)-ethyl -amino]-propan-2-ol[carvedilol]
10/10/2001EP1142873A2 Process for preparing 1-[9'H-carbazol-4'-yloxy]-3-[ 2''-(2'''- methoxy -phenoxy)-ethyl -amino]-propan-2-ol[carvedilol]
10/10/2001EP1142867A2 Cell adhesion inhibitors
10/10/2001EP1141409A1 A system and methods for nucleic acid sequencing of single molecules by polymerase synthesis
10/10/2001EP1141138A1 Phthalimidyl azo pigments, method for producing same and utilisation thereof
10/10/2001EP1141038A1 Method of producing a polymer network
10/10/2001EP1140936A1 Tricyclic inhibitors of poly(adp-ribose) polymerases
10/10/2001EP1140914A1 Non-peptide nk1 receptors antagonists
10/10/2001EP1140901A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
10/10/2001EP1140898A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands
10/10/2001EP1140887A1 Phase transfer catalyzed method for preparing oxybisphthalic compounds
10/10/2001EP1140859A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/10/2001EP1140840A1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
10/10/2001EP1140828A1 3-azabicyclo[3.1.0]hexane derivatives as opiate receptors ligands
10/10/2001EP1140827A1 Synthesis of phenolic monomers containing imide or diimide moieties and high heat carbonate polymers prepared therefrom
10/10/2001EP1140826A1 Method for producing (2s,4r,9s)-octahydro-1h-indole-2-carboxylic acid and intermediate products therefor
10/10/2001EP1140825A1 Melatonin derivatives and medicine containing same
10/10/2001EP1140824A1 Method for producing 3-alkanoylindoles and 3-alkylindoles
10/10/2001EP1140823A1 Glucagon antagonists/inverse agonists
10/10/2001EP1140818A1 Amidomalonamides and their use as inhibitors of matrix metalloproteinase
10/10/2001EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/10/2001EP1140802A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines
10/10/2001EP1140792A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
10/10/2001EP1140783A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
10/10/2001EP1140768A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
10/10/2001EP1140074A1 Indole and indolizidine derivatives for the treatment of migraine
10/10/2001EP0832065B1 Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
10/10/2001EP0764163B1 Tachykinin (nk 1) receptor antagonists
10/09/2001US6300366 Aminopyrroline compounds
10/09/2001US6300363 Indole compounds as COX-2 inhibitors
10/09/2001US6300342 Antithrombotic phenylalkyl derivatives
10/09/2001US6300341 2-substituted heterocyclic sulfonamides
10/09/2001US6300340 Useful for therapy of cancer and solid tumors
10/09/2001CA2177147C 2-oxoindoline derivative
10/09/2001CA2119662C New nitrogen bicyclic derivatives, their preparation process and pharmaceutical compositions comtaining them
10/04/2001WO2001072752A2 2,3,4,5-TETRAHYDRO-1H-[1,4]DIAZEPINO[1,7-a]INDOLE COMPOUNDS
10/04/2001WO2001072716A1 An intermediate and process for its synthesis
10/04/2001WO2001072707A2 Carbamate caspase inhibitors and uses thereof
10/04/2001WO2001072692A1 Malonamic acids and derivatives thereof as thyroid receptor ligands
10/04/2001WO2001072685A2 Polyamine analogues as cytotoxic agents
10/04/2001WO2001072673A1 Anthracene derivatives and organic electroluminescent devices made by using the same
10/04/2001WO2001021577A3 Melanin concentrating hormone antagonist
10/04/2001US20010027207 Modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation; anticarcinogenic, -diabetic, -proliferative and -inflammatory agents; vascular system disorders
10/04/2001US20010027202 Antitumor and -carcinogenic agents; solid cancers, e.g carcinomas of the lungs, pancreas, thyroid, bladder or color, myeloid disorders, e.g. leukemia or adenomas, e.g villous colon adenoma
10/04/2001US20010027174 Polypeptides containing neo-tryptophan; neurotensin analogs; neotryptophan derivatives; method of synthesis starting from 2-methyl-3-nitrobenzoic acid; administering to a mammal having a serotonin recognition molecule
10/04/2001EP1138744A1 Organic electroluminescent element
10/04/2001EP1138682A1 Novel water soluble c-ring analogues of 20 (s)-camptothecin
10/04/2001EP1138674A1 Crystalline forms of 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide
10/04/2001EP1137739A1 Catalytic cracking process using an mcm-68 catalyst
10/04/2001EP1137647A1 Thiourea inhibitors of herpes viruses
10/04/2001EP1137633A2 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
10/04/2001EP0853614B1 Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors
10/04/2001EP0815105B1 Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists
10/04/2001EP0757673B1 Heterocyclylbenzonitriles
10/04/2001EP0552329B1 Methylen-oxindole derivatives and process for their preparation
10/04/2001DE10015939A1 Thrombolytic agent useful e.g. for treating or preventing deep vein leg thrombosis, pulmonary embolism or restenosis comprises new or known 3-phenyl-4,5-dihydro-2-phenylbenz(e)indole derivatives
10/04/2001CA2403814A1 Polyamine analogues as cytotoxic agents
10/04/2001CA2402472A1 2,3,4,5-tetrahydro-1h-¬1,4|diazepino¬1,7a|indole compounds
10/03/2001CN1072213C Process for producing guanidine derivatives, intermediates therefor
10/03/2001CN1072209C Benzonitriles and benzofluorides
1 ... 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 ... 458